Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
1997-06-04
2003-04-08
Duffy, Patricia A. (Department: 1645)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S388100, C530S388400, C530S391100, C530S391300, C530S391700
Reexamination Certificate
active
06545130
ABSTRACT:
BACKGROUND OF THE INVENTION
Tuberculosis continues to be a major worldwide health problem and is responsible for most incidences of death by an infectious agent. The worldwide incidence of tuberculosis was estimated by the World Health Organization to be 8.8 million in 1995, with a mortality estimate of 3.0 million persons, and is expected to rise to 10.2 million by the year 2000 (Dolin, et al.,
Bull. WHO.
72: 213-220 (1994)). The tuberculosis problem has been compounded by the development of the AIDS epidemic and the growing number of HIV-related cases of tuberculosis (Dolin, et al.,
Bull. WHO.
72: 213-220 (1994)).
As the incidence of tuberculosis increases, major problems also develop concerning this disease. For example, the lack of a sensitive and rapid laboratory method of diagnosing tuberculosis makes it difficult to differentiate between
M. tuberculosis
and
M. avium
-
intracellulare,
both of which are frequently present in HIV infected patients. Multiple methods of detection of
M. tuberculosis
employing polyclonal and monoclonal antibodies have been described (Cho, et al.,
Yonsei Med. J.
31:333-338 (1990); Cho, et al.,
J. Clin. Microbiol.
30: 3065-3069 (1992); Friedman, et al.,
Am. Rev. Respir. Dis.
140: 668-671 (1989); Kadival, et al.,
J. Clin. Microbiol.
23: 901-904(1986); Mason, et al.,
Tubercle Lung Dis.
74:195-199(1993); Papa, et al.,
Res. Microbiol.
143: 327-331 (1992); Sada, et al.,
Lancet
2 651-652 (1983); Schoningh, et al.,
J. Clin. Microbiol.
28: 708-713 (1990); Verstijnen, et al.,
J. Clin. Microbiol.
29:1372-1375 (1991) Watt, et al.,
J Infect Dis.
158:681-686 (1988); Wu, et al.,
Chin. J. Microbiol. Immunol.
22:173-180 (1989); Yanez, et al.,
Clin. Microbiol.
23: 822-825 (1986)), but none have acquired a widespread role in the diagnosis of tuberculosis as these antibodies cross-react with other mycobacterial strains (Cho, et al.,
Yonsei Med. J.
31:333-338 (1990); Friedman, et al.,
Am. Rev. Respir. Dis.
140: 668-671 (1989); Kadival, et al.,
J. Clin. Microbiol.
23: 901-904 (1986); Wu, et al.,
Chin. J. Microbiol. Immunol.
22:173-180 (1989); Yanez, et al.,
J. Clin. Microbiol.
23: 822-825 (1986)). In addition, in order to obtain significant results, a large amount of mycobacteria or mycobacterial antigen is required (Cho, et al.,
J. Clin. Microbiol.
30: 3065-3069 (1992); Mason, et al.,
Tubercle Lung Dis.
74:195-199 (1993); Papa, et al.,
Res. Microbiol.
143: 327-331 (1992); Schoningh, et al.,
J. Clin. Microbiol.
28: 708-713 (1990); Verstijnen, et al.,
J. Clin. Microbiol.
29:1372-1375 (1991)). Improvements in antibody-based diagnostic tests for the detection of
M. tuberculosis
would require specific antibody reagents with high affinity for mycobacterial antigens. Several monoclonal antibodies have been generated against surface components of
M. tuberculosis
(Cho, et al.,
Yonsei Med. J.
31:333-338 (1990); Cho, et al.,
J. Clin. Microbiol.
30: 3065-3069 (1992); Mauch, et al.,
J. Clin. Microbiol.
26:1691-1694 (1988)) but they are often cross reactive with other strains or cytoplasmic fractions (Cho, et al.,
Yonsei Med. J.
31:333-338 (1990); Mauch, et al.,
J. Clin. Microbiol.
26:1691-1694 (1988)). There is thus a need for a monoclonal antibody that selectively binds to
M. tuberculosis
and does not cross react with other strains of mycobacteria.
An additional problem concerns the protocol used for detecting
M. tuberculosis.
The protocols described thus far for detecting mycobacteria, such as direct ELISA (Mason, et al.,
Tubercle Lung Dis.
74:195-199 (1993); Schoningh, et al.,
J. Clin. Microbiol.
28: 708-713 (1990); Verstijnen, et al.,
J. Clin. Microbiol.
29:1372-1375 (1991)), capture ELISA (Cho, et al.,
Yonsei Med. J.
31:333-338 (1990); Cho, et al.,
J. Clin. Microbiol.
30: 3065-3069 (1992); Friedman, et al.,
Am. Rev. Respir. Dis.
140: 668-671 (1989); Kadival, et al.,
J. Clin. Microbiol.
23: 901-904 (1986); Rattan, et al.,
Tubercle Lung Dis.
74: 200-203 (1993); Sada, et al.,
Lancet
2 651-652 (1983); Watt, et al.,
J Infect Dis.
158:681-686 (1988); Wu, et al.,
Chin. J. Microbiol. Immunol.
22:173-180 (1989); Yanez, et al.,
J. Clin. Microbiol.
23: 822-825 (1986)) and DOT ELISA (Cho, et al.,
J. Clin. Microbiol.
30: 3065-3069 (1992); Papa, et al.,
Res. Microbiol.
143: 327-331 (1992)), are deficient in many areas. For example, none of the methods listed above allow for visualization of single captured microorganisms. Furthermore, many of these methods require the use of polyclonal immunoglobulins which have the potential disadvantages of lot to lot variation, reliance on animal sources and unwanted cross-reactivities. Accordingly, there is an outstanding need for a method of detecting
M. tuberculosis
which eliminates the problems existing in current methods of detection.
SUMMARY OF THE INVENTION
The present invention provides for monoclonal antibodies, the hybridoma cell lines which produce these antibodies, and the use of such monoclonal antibodies in the detection of
M. tuberculosis
. More specifically, the present invention provides for monoclonal antibodies that react with surface epitopes of
M. tuberculosis
and the use of these monoclonal antibodies for detecting and diagnosing
M. tuberculosis.
Also provided by the present invention is a modified ELISA assay for detection of microorganisms, and a modified ELISA assay employing the monoclonal antibodies of the present invention for detecting
M. tuberculosis.
REFERENCES:
patent: 5770719 (1998-06-01), Kapoor et al.
Glatman-Freedman et al p287 95thASM General Mtg. Abstract E-36, 1995.*
Rambukkana et al, Scand. J. Immunol. 33:763-775, 1991.*
Glatman-Freedman et al, Infection & Immunity 68/1:335-341, 2000.*
Teitelbaum et al, PNAS, 95:15688-15693, Dec. 1998.*
Wagner et al, Med. Microbiol. Immunol 181/1:25-33 (Abstract Only), 1992.*
Ortalo-Magné, Microbiology 141:1609-1620, 1995.*
Catty et al In : Antibodies, vol. II, IrL Press at Oxford University pp. 97-154, 1989.*
Tijssenin “Practice and theory of enzyme immunoassays”, Elsevier Science Publishers B. V. 1985 , pp. 117-121.*
Glatman-Freedman et al 1998 Clin. Microbiol. Rev. 11(3):514-532, 1998.*
Cho et al J. Clin. Microbiol, 30(12):3065-3069, 1992.*
Rambukkana et al. Scand. J. Immunol 33:763-775, 1991.*
Schöningh et al J. Clin. Microbiol 28(4):708-713, 1990.*
Glatman-Freedman et al, J. Clin. Microbiol 34(11):2795-2802, 1996.*
Mason et al, Tubercle & Lung Disease, 74:195-199, 1993.*
Bothamley, Eur. Respin. J.; 8, Suppl 20:6765-6885, 1995.*
Papa, et al., DOT-ELISA for detection of phenolic glycolipid PGL-Tbl and diacyl-trehalose antigens of Mycobacterium tuberculosis, Res. Microbiol., 1992, 143. 327-331.
Mauch, et al., Monoclonal Antibodies Selectively Directed against the Cell Wall Surface of Mycobacterium Tuberculosis, J. Clin. Microbiol., 1988, 26(9), 1691-1694.
Wu, et al., Detection of Mycobacterial Antigens in Cerebrospinal Fluid by Enzyme-Linked Immunosorbent Assay Utilizing Anti-Mycobacterial Saline Extract Antibodies, Chinese J. Microbiol. Immunol. 1989. 22. 173-180.
Kolk, et al., Production and Characterization of Monoclonal Antibodies to Mycobacterium Tuberculosis, M. Bovis (BCG) and M. leprae, Clin. Exp. Immunol. 1984. 58. 511-521.
Friedman, et al., ELISA Analysis of BACTEC Bottles for the Earlier Diagnosis of Tuberculosis, American Review of Resp. Dis., 140(3):668-71, 1989.
Verstijnen, et al., Enzyme-Linked Immunosorbent Assay Using Monoclonal Antibodies for Identification of Mycobacteria from Early Cultures, J. Clin. Microbiol . . . 29(7). 1991. 1372-1375.
Kadival, et al., Sensitivity and Specificity of Enzyme-Linked Immunosorbent Assay in the Detection of Antigen in Tuberculosis Meningitis Cerebrospinal Fluids, J. Clin. Microbiol., 1986, 23(5); 901-904.
Cho, et al., Production of Monoclonal Antibodies to Lipoarabinomannan-B and use in the Detection of Mycobacterial Antigens in Sputum, Yonsei Medical Journal, 31(4), 1990, 333-338.
Casadevall Arturo
Glatman-Freedman Aharona
Albert Einstein College of Medicine of Yeshiva University
Amster Rothstein & Ebenstein
Duffy Patricia A.
LandOfFree
Monoclonal antibodies to mycobacterium tuberculosis and a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies to mycobacterium tuberculosis and a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies to mycobacterium tuberculosis and a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3045574